Moreover, investigation of differentially expressed transcripts in livers of people with non-alcoholic fatty liver disease (NAFLD) found that SCLY was downregulated in non-alcoholic steatohepatitis (NASH) compared with healthy controls [17]. This evidence concerns the gene SCLY and metabolic dysfunction-associated steatotic liver disease.